Krilogy Financial LLC Purchases Shares of 2,887 Cardinal Health, Inc. $CAH

Krilogy Financial LLC acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,887 shares of the company’s stock, valued at approximately $453,000.

Several other large investors also recently modified their holdings of the stock. Advisors Asset Management Inc. boosted its holdings in shares of Cardinal Health by 7.0% during the 3rd quarter. Advisors Asset Management Inc. now owns 21,344 shares of the company’s stock worth $3,350,000 after buying an additional 1,399 shares during the period. Stratos Wealth Partners LTD. lifted its position in Cardinal Health by 2.1% during the third quarter. Stratos Wealth Partners LTD. now owns 6,854 shares of the company’s stock worth $1,076,000 after acquiring an additional 144 shares during the last quarter. MQS Management LLC bought a new stake in shares of Cardinal Health during the third quarter worth approximately $624,000. Versor Investments LP acquired a new position in shares of Cardinal Health in the third quarter valued at approximately $2,090,000. Finally, Candriam S.C.A. increased its stake in shares of Cardinal Health by 10.8% during the third quarter. Candriam S.C.A. now owns 196,163 shares of the company’s stock worth $30,790,000 after purchasing an additional 19,155 shares during the period. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Up 2.6%

CAH stock opened at $220.72 on Friday. Cardinal Health, Inc. has a 52 week low of $120.72 and a 52 week high of $230.81. The business has a 50-day simple moving average of $208.84 and a 200 day simple moving average of $182.37. The company has a market cap of $51.94 billion, a PE ratio of 31.76, a price-to-earnings-growth ratio of 1.42 and a beta of 0.64.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, February 5th. The company reported $2.63 EPS for the quarter, beating the consensus estimate of $2.31 by $0.32. The firm had revenue of $65.63 billion for the quarter, compared to analyst estimates of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The business’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period last year, the firm earned $1.93 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Wednesday, April 1st. This represents a $2.04 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio is presently 29.35%.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent quarterly results and underlying strength — Cardinal reported a Q4 EPS beat and revenue above expectations, with revenue up ~19% year-over-year, which analysts cite as supporting the stock’s upside. Cardinal Health’s (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors
• Positive Sentiment: Dividend confirmed — the Board approved a quarterly dividend of $0.5107 per share (payable Apr 15; record Apr 1). The cash return reinforces income appeal and signals confidence in cash flow. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Analyst lift — JPMorgan raised its price target to $243, providing a tangible upside anchor for investors and helping sentiment. JPMorgan Chase Increases Cardinal Health Price Target
• Positive Sentiment: Zacks momentum & valuation coverage — CAH was added to Zacks’ Rank #1 momentum list and several Zacks pieces highlight undervaluation and a favorable long-term value case, which can attract momentum and value investors. Best Momentum Stock to Buy for February 13th Are Investors Undervaluing Cardinal Health?
• Neutral Sentiment: Kalkine notes logistics/reliability improvements on the NYSE composite — operational reliability updates are constructive but are incremental near-term drivers. Cardinal Health Boosts Logistics Reliability
• Neutral Sentiment: Analyst Q&A from the earnings call — the transcript highlights management’s priorities and risk items; useful for longer-term fundamental assessment but not an immediate catalyst. The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call

Wall Street Analyst Weigh In

Several research firms recently issued reports on CAH. Deutsche Bank Aktiengesellschaft boosted their price target on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Argus boosted their target price on shares of Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research report on Wednesday. TD Cowen upped their price target on shares of Cardinal Health from $233.00 to $251.00 and gave the company a “buy” rating in a research note on Wednesday. Leerink Partners raised their price target on shares of Cardinal Health from $240.00 to $268.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Finally, UBS Group set a $260.00 price objective on shares of Cardinal Health and gave the company a “buy” rating in a report on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $245.19.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.